Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18461006 | 0.88 | IDO1 (0.33) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| Iodide SCHEMBL28621234 | 0.86 | IDO1 (0.32) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL28645887 | 0.86 | IDO1 (0.32) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL2275519 | 0.84 | IDO1 (0.31) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL22792410 | 0.84 | FABP3 (0.33) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL849668 | 0.84 | IDO1 (0.31) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL12582085 | 0.84 | IDO1 (0.50) | IDO1KDM4EMAPTALDH1A1TDP1 | |
| SCHEMBL9801566 | 0.80 | MAPT (0.46) | IDO1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL12702785 | 0.80 | APP (0.42) | MAPTALDH1A1TDP1L3MBTL1USP2 | |
| SCHEMBL10557748 | 0.78 | IDO1 (0.32) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7777063-B2 | Organosilicon compounds their preparation and their use | EVONIK DEGUSSA GMBH (DE) | 2010-08-17 | — | — | US | disclosed |
| US-7777063-B2 | Organosilicon compounds their preparation and their use | EVONIK DEGUSSA GMBH (DE) | 2010-08-17 | — | — | US | disclosed |
| US-20070066760-A1 | Organosilicon compounds their preparation and their use | DEGUSSA AG (DE) | 2007-03-22 | — | — | US | disclosed |
| US-20070066760-A1 | Organosilicon compounds their preparation and their use | DEGUSSA AG (DE) | 2007-03-22 | — | — | US | disclosed |
| EP-1056874-A1 | CONVERSION AND REMOVAL OF STEROID GLYCOALKALOIDS | Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.A. (NL) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999043837-A1 | CONVERSION AND REMOVAL OF STEROID GLYCOALKALOIDS | COÖPERATIEVE VERKOOP- EN PRODUCTIEVERENIGING VAN AARDAPPELMEEL EN DERIVATEN AVEBE B.A. (NL) | 1999-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066760-A1 | Organosilicon compounds their preparation and their use | MSH6, MCM6, SI | IDO1 2289/4885KDM4E 2034/4885MAPT 1545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.